Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery

British Journal of Anaesthesia

Volumn 113, Issue 2, 2014, Pages 296-298

  Rineau, E ^a   Chaudet, A ^a   Carlier, L ^a   Bizot, P ^a   Lasocki, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL PAIN; AGED; ANEMIA; BLOOD TRANSFUSION; CONSTIPATION; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PREOPERATIVE COMPLICATION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT RESPONSE; URINE COLOR;

AGED; DRUG SYNERGISM; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; HEMATINICS; HEMOGLOBINS; HUMANS; IRON; MALE; MALTOSE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PREOPERATIVE CARE; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, ELECTIVE;

EID: 84905650890     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu245     Document Type: Letter

References (15)

1. Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet 2013; 381: 1855-65
2. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, andmanagementofpreoperativeanaemia in theelectiveorthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22
3. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68
4. Faris P. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med 1996; 101: 28-32S
5. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, et al. Tolerability of different oral ironsupplements:asystematic review.CurrMedRes Opin 2013; 29: 291-303
6. Bonnar J, GoldbergA, Smith JA.Dopregnantwomentake their iron? Lancet 1969; 1: 457-8
7. Lyseng-WilliamsonKA, KeatingGM.Ferriccarboxymaltose:areview of its use in iron-deficiency anaemia. Drugs 2009; 69: 739-56
8. Moore RA, Gaskell H, Rose P, Allan J. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) fromclinical trial reports and published trial data. BMC Blood Disord 2011; 11: 4
9. Kotzé A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-52
10. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statementontheroleof intravenousiron. Br JAnaesth2008;100:599-604 (Pubitemid 351774360)
11. Theusinger OM, Leyvraz P-F, Schanz U, Seifert B, Spahn DR. Treatmentof irondeficiencyanemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 2007; 107: 923-7 (Pubitemid 350175674)
12. Piednoir P, Allou N, Driss F, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur J Anaesthesiol 2011; 28: 796-801
13. Krayenbuehl P-A, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatmentof fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011; 118: 3222-7
14. Brownlie T, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004; 79: 437-43 (Pubitemid 41115588)
15. Agarwal R. Nonhematological benefits of iron. Am J Nephrol 2007; 27: 565-71 (Pubitemid 350014943)